Metabolomic estimation of the diagnosis of hepatocellular carcinoma based on ultrahigh performance liquid chromatography coupled with time-of-flight mass spectrometry
Open Access
- 6 March 2018
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 8 (17) , 9375-9382
Abstract
Metabolomics has been shown to be an effective tool for biomarker screening and pathway characterization and disease diagnosis. Metabolic characteristics of hepatocellular carcinoma (HCC) may enable the discovery of novel biomarkers for its diagnosis. In this work, metabolomics was used to investigate metabolic alterations of HCC patients. Plasma samples from HCC patients and age-matched healthy controls were investigated using high resolution ultrahigh performance liquid chromatography-mass spectrometry and metabolic differences were analyzed using pattern recognition methods. 23 distinguishable metabolites were identified. The altered metabolic pathways were associated with arginine and proline metabolism, glycine, serine and threonine metabolism, steroid hormone biosynthesis, starch and sucrose metabolism, etc. To demonstrate the utility of plasma biomarkers for the diagnosis of HCC, five metabolites comprising deoxycholic acid 3-glucuronide, 6-hydroxymelatonin glucuronide, 4-methoxycinnamic acid, 11b-hydroxyprogesterone and 4-hydroxyretinoic acid were selected as candidate biomarkers. These metabolites that contributed to the combined model could significantly increase the diagnostic performance of HCC. It has proved to be a powerful tool in the discovery of new biomarkers for disease detection and suggest that panels of metabolites may be valuable to translate our findings to clinically useful diagnostic tests.Keywords
Funding Information
- Natural Science Foundation of Heilongjiang Province (H2015038)
- Heilongjiang University of Chinese Medicine (2014bs08)
This publication has 27 references indexed in Scilit:
- Nuclear magnetic resonance based metabolomics and liver diseases: Recent advances and future clinical applicationsWorld Journal of Gastroenterology, 2016
- Metabolomics Identifies Biomarker Pattern for Early Diagnosis of Hepatocellular Carcinoma: from Diethylnitrosamine Treated Rats to PatientsScientific Reports, 2015
- GC-MS Based Plasma Metabolomics for Identification of Candidate Biomarkers for Hepatocellular Carcinoma in Egyptian CohortPLOS ONE, 2015
- Integrative Genomic Signatures Of Hepatocellular Carcinoma Derived from Nonalcoholic Fatty Liver DiseasePLOS ONE, 2015
- Metabolic fingerprinting to understand therapeutic effects and mechanisms of silybin on acute liver damage in ratPharmacognosy Magazine, 2015
- Development of Urinary Pseudotargeted LC-MS-Based Metabolomics Method and Its Application in Hepatocellular Carcinoma Biomarker DiscoveryJournal of Proteome Research, 2014
- Non-invasive Biomarkers in Non-Alcoholic Steatohepatitisinduced Hepatocellular CarcinomaJournal of Gastrointestinal and Liver Diseases, 2014
- Metabolic profiling study of early and late recurrence of hepatocellular carcinoma based on liquid chromatography-mass spectrometryJournal of Chromatography B, 2014
- Metabolite fingerprint analysis of cervical cancer using LC-QTOF/MS and multivariate data analysisAnalytical Methods, 2014
- 1-Stearoylglycerol is associated with risk of prostate cancer: results from a serum metabolomic profiling analysisMetabolomics, 2014